摘要
慢性心力衰竭（chronic heart failure，CHF）是人们日益关注的公共健康问题，是各种心脏疾患的终末阶段，其发病率呈逐年上升趋势。尽管近几十年来，CHF的药物和非药物治疗在改善患者临床症状和预后方面有了较大进展，但CHF的死亡率仍很高。
出处
《中国医学创新》
CAS
2011年第25期185-186,共2页
Medical Innovation of China
参考文献16
-
1Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe ,resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitali- zations. J Am Coil Cardio1,2000,35 ( 7 ) : 1737 - 1744. 被引量：1
-
2Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes : insights from a co- hort of 12065 patients with new onset heart failure. Circulation, 2003,107(2) :223 -225. 被引量：1
-
3叶长青,郑兴.住院慢性心衰患者贫血患病率与心功能的关系及血红蛋白浓度对其住院死亡率的影响[J].第二军医大学学报,2006,27(9):977-980. 被引量：9
-
4Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in he- moglobin over time related to mortality and morbidity in patients with chronic heart failure results from Val - Heft. Circulation,2005,112 (8) :1121 - 1127. 被引量：1
-
5Androne AS, Katz SD, Lund L, et al. Hemodilution is common in pa- tients with advanced heart failure. Circulation, 2003, 107 (2): 226 - 229. 被引量：1
-
6Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severetive heart failure. Eur J Heart Fail ,2002,4 (6) :681 - 686. 被引量：1
-
7Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE inhibitors or ATI antagonists. Eur J Heart Fail,2000,2 (4) : 393 - 398. 被引量：1
-
8Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin - conveyting en- zyme inhibitor as a risk f actor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Gardiol,2005,45 (3) :391 - 399. 被引量：1
-
9Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symtoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart fail- ure. J Am Coll,2002,39 ( 11 ) : 1780 - 1786. 被引量：1
-
10Sharma R, Francis DP, Pitt B, et al. Haemoglobin predicts survival in patients with chronic heart failure :a sub study of the ELITE Ⅱ trial. Eur Heart J,2004,25 (12) :1021 - 1028. 被引量：1
二级参考文献17
-
1Sharma R,Francis D,Pitt B,et al.Hemoglobin predicts survival in patients with chronic heart failure:a substudy of the ELITE Ⅱ trial[J].Eur Heart J,2004,25:1021-1028. 被引量：1
-
2Ezekowitz JA,McAlister FA,Armstrong PW.Anemia is common in heart failure and is associated with poor outcomes:insights from a cohort of 12,065 patients with new-onset heart failure[J].Circulation,2003,107:223-225. 被引量：1
-
3Al-Ahmad A,Rand WM,Manjunath G,et al.Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction[J].J Am Coll Cardiol,2001,38:955-962. 被引量：1
-
4Felker GM,Gattis WA,Leimberger JD,et al.Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure[J].Am J Cardiol,2003,92:625-628. 被引量：1
-
5Nordyke RJ,Kim JJ,Goldberg GA,et al.Impact of Anemia on hospitalization time,charges,and mortality in patients with heart failure[J].Value Health,2004,7:464-471. 被引量：1
-
6Mehra MR,Uber PA,Francis GS.Heart failure therapy at a crossroad:are there limits to the neurohormonal model[J]? J Am Coll Cardiol,2003,41:1606-1610. 被引量：1
-
7Horwich TB,Fonarow GC,Hamilton MA,et al.Anemia is associated with worse symptoms,greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure[J].J Am Coll Cardiol,2002,39:1780-1786. 被引量：1
-
8Silverberg DS,Wexler D,Sheps D,et al.The effect of correction of mild anemia in severe,resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron:a randomized controlled study[J].J Am Coll Cardiol,2001,37:1775-1780. 被引量：1
-
9Silverberg DS,Wexler D,Blum M,et al.The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe,resistant congestive heart failure improves cardiac and renal function and functional cardiac class,and markedly reduces hospitalizations[J].J Am Coll Cardiol,2000,35:1737-1744. 被引量：1
-
10Pentimone F,Del Corso L,Frustaci G,et al.Clinical evaluation of anemia in the aged[J].Minerva Med,1992,83:35-39. 被引量：1
共引文献8
-
1何如平,刘品明.充血性心力衰竭性贫血的研究进展[J].国际内科学杂志,2008,35(1):30-33. 被引量：2
-
2张善春,齐惠英,杜闻莹,郑刚,李广平.内源性促红细胞生成素水平和肾功能对慢性心力衰竭患者贫血的影响[J].中国医药导刊,2008,10(2):188-191. 被引量：5
-
3李慧.慢性充血性心力衰竭辨治探讨[J].山西中医,2009,25(2):1-3. 被引量：6
-
4冯冰,王浩,沈元弟,王琥,王红娣,唐静怡.蔗糖铁联合促红细胞生成素治疗老年糖尿病患者慢性心衰合并贫血[J].医药论坛杂志,2009,30(16):1-2. 被引量：4
-
5周巍,赵英强.慢性心衰伴发贫血的中医治疗探讨[J].吉林中医药,2010,30(1):27-28. 被引量：2
-
6纪明,饶大勇,毛尚,张利进,刘在军.慢性充血性心力衰竭患者合并贫血的临床分析[J].四川医学,2011,32(3):391-393. 被引量：1
-
7温馨,黄炜,韩晓东.加味当归补血汤治疗慢性心衰伴贫血患者的疗效观察[J].中西医结合心血管病电子杂志,2020,8(31):160-160. 被引量：4
-
8杨汉跃,董淑波,陈学民.新型PHD抑制剂类口服抗贫血药物分子的计算机辅助设计[J].药物化学,2017,5(2):17-23.
同被引文献44
-
1高艳玲,林宏扬,葛志明.心力衰竭性贫血的研究进展[J].中国老年学杂志,2004,24(11):1088-1090. 被引量：12
-
2马依彤,李霞,王朝霞.慢性心力衰竭患者中贫血的患病情况[J].临床心血管病杂志,2007,23(1):37-39. 被引量：6
-
3郭玲,王爱红,吕琳,鹿克风,孙永乐.EPO辅助治疗慢性心力衰竭合并贫血52例临床观察[J].山东医药,2007,47(5):57-58. 被引量：10
-
4郗爱旗,褚以德,钟欣,李英兰,廖宝霞,尚玲,李国峰,赵文蕊.慢性心力衰竭患者贫血与肾功能和神经内分泌细胞因子的关系[J].中华老年心脑血管病杂志,2008,10(1):24-26. 被引量：7
-
5Nagaya N,Miyatake K,Uematsu M,et al.Hemodynamic,renal,and hormonal effects of ghrelin infusion in patients with chronic heart failure[J].J Clin Endocrinol Metab,2001,86(12):5854-5859. 被引量：1
-
6Nagaya N,Kangawa K.Therapeutic potential of ghrelin in the treatment of heart failure[J].Drugs,2006,66(4):439-448. 被引量：1
-
7Nagaya N,Kojima M,Uematsu M,et al.Hemodynamic and hormonal effects of human ghrelin in healthy volunteers[J].Am J Physiol Regul Integr Comp Physiol,2001,280(5):1483-1487. 被引量：1
-
8Nagaya N,Kangawa K.Ghrelin,a novel growth hormonereleasing petide,in the treatment of chronic heart failure[J].Regul Pept,2003,114(2-3):71-77. 被引量：1
-
9Nagaya N,Uematsu M,Kojima M,et al.Elevated circulating level of ghrelin in cachexia associated with chronic heart failure:relationships between ghrelin and anabolic/catabolic factors[J].Circulation,2001,104(17):2034-2038. 被引量：1
-
10Xu J P,Wang H X,Wang W,et al.Ghrelin improves disturbed myocardial energy metabolism in rats with heart failure induced by isoproterenol[J].J Pept Sci,2010,16(8):392-402. 被引量：1
引证文献3
-
1张维波,傅强,陈成,陈景亮.老年慢性心力衰竭患者血浆ghrelin浓度变化及意义研究[J].中国医学创新,2016,13(17):15-18. 被引量：2
-
2罗翊芝,梁转合,陶卫国,宋飞月,朱可云.复方硫酸亚铁叶酸片对慢性心力衰竭合并缺铁性贫血患者的疗效[J].中国医学创新,2017,14(13):16-19. 被引量：4
-
3吴博华,谢爵隆,何航宇.贫血对首诊急性心力衰竭患者1年死亡率的影响相关研究[J].中国医学创新,2018,15(13):124-127. 被引量：1
二级引证文献7
-
1杨素云,刘镇,古春花,黄丽华,彭智勇,徐连登,郑献敏,陈伟军,彭俊杰,云维峥.慢性心力衰竭患者外周血清CA125水平与NT-proBNP水平、心功能的相关性研究[J].中国医学创新,2017,14(15):23-26. 被引量：5
-
2吴博华,谢爵隆,何航宇.贫血对首诊急性心力衰竭患者1年死亡率的影响相关研究[J].中国医学创新,2018,15(13):124-127. 被引量：1
-
3贾蕾蕾,卢家忠,李增.Ghrelin与心房颤动的相关性研究[J].蚌埠医学院学报,2018,43(12):1558-1560.
-
4钟燕玲,梁采平,刘俏敏.复方硫酸亚铁叶酸片治疗妊娠期缺铁性贫血的临床效果[J].中国当代医药,2019,26(1):58-60. 被引量：8
-
5邓向群,黄姿.小剂量递增补铁法治疗小儿中度缺铁性贫血的临床效果[J].中国医药科学,2019,9(4):7-9. 被引量：6
-
6朱芳玲,朱群英,黄慧娟.不同剂量复方硫酸亚铁叶酸片治疗妊娠期缺铁性贫血的临床研究[J].药品评价,2019,16(22):85-86. 被引量：4
-
7赖雪,韦静,罗雪,李春燕,覃苑瑗.心力衰竭病人死亡现状及影响因素的研究进展[J].全科护理,2023,21(2):197-202. 被引量：3
-
1吴少琴,卢益中.血浆B型利钠肽快速测定鉴别心源性和肺源性呼吸困难[J].临床急诊杂志,2006,7(1):27-28. 被引量：2
-
2周素贞,洪葵.心力衰竭性室性心律失常的发生机制[J].新医学,2011,42(4):269-271. 被引量：6
-
3刘训宏.78例心包疾病的临床分析[J].江苏医药,1997,23(3):179-180.
-
4杜文惠,路裕华.心力衰竭性心包积液22例临床分析[J].中国冶金工业医学杂志,1994,11(1):28-29.
-
5高艳玲,林宏扬,葛志明.心力衰竭性贫血的研究进展[J].中国老年学杂志,2004,24(11):1088-1090. 被引量：12
-
6袁绍伦.充血性心力衰竭性心包积液47例临床分析[J].临床荟萃,1998,13(14):639-640.
-
7何如平,刘品明.充血性心力衰竭性贫血的研究进展[J].国际内科学杂志,2008,35(1):30-33. 被引量：2
-
8惠勇,唐忠仁.16例心包积液病因及误诊分析[J].中国中医药咨讯,2011,3(17):186-186.
-
9周永明,易欣,黎明江.心包积液的病因及误诊分析[J].临床和实验医学杂志,2012,11(19):1531-1532. 被引量：1
-
10徐成胜,吴勇波,何涛,王琼昕,周千星,曾和松.心包积液住院患者的病因分析(附384例报告)[J].临床心血管病杂志,2008,24(10):794-795. 被引量：16
